IRIS Accounts Production v24.2.0.383 07596770 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false Ordinary B 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075967702023-03-31075967702024-03-31075967702023-04-012024-03-31075967702022-03-31075967702022-04-012023-03-31075967702023-03-3107596770ns15:EnglandWales2023-04-012024-03-3107596770ns14:PoundSterling2023-04-012024-03-3107596770ns10:Director12023-04-012024-03-3107596770ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107596770ns10:SmallEntities2023-04-012024-03-3107596770ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3107596770ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107596770ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107596770ns10:FullAccounts2023-04-012024-03-310759677012023-04-012024-03-3107596770ns10:OrdinaryShareClass12023-04-012024-03-3107596770ns10:OrdinaryShareClass22023-04-012024-03-3107596770ns10:Director22023-04-012024-03-3107596770ns10:RegisteredOffice2023-04-012024-03-3107596770ns5:CurrentFinancialInstruments2024-03-3107596770ns5:CurrentFinancialInstruments2023-03-3107596770ns5:ShareCapital2024-03-3107596770ns5:ShareCapital2023-03-3107596770ns5:RetainedEarningsAccumulatedLosses2024-03-3107596770ns5:RetainedEarningsAccumulatedLosses2023-03-3107596770ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107596770ns5:FurnitureFittings2023-04-012024-03-3107596770ns5:MotorVehicles2023-04-012024-03-3107596770ns5:ComputerEquipment2023-04-012024-03-3107596770ns5:NetGoodwill2023-03-3107596770ns5:NetGoodwill2024-03-3107596770ns5:NetGoodwill2023-03-3107596770ns5:FurnitureFittings2023-03-3107596770ns5:MotorVehicles2023-03-3107596770ns5:ComputerEquipment2023-03-3107596770ns5:FurnitureFittings2024-03-3107596770ns5:MotorVehicles2024-03-3107596770ns5:ComputerEquipment2024-03-3107596770ns5:FurnitureFittings2023-03-3107596770ns5:MotorVehicles2023-03-3107596770ns5:ComputerEquipment2023-03-3107596770ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-03-3107596770ns5:UnlistedNon-exchangeTraded2024-03-3107596770ns5:UnlistedNon-exchangeTraded2023-03-3107596770ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107596770ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3107596770ns10:OrdinaryShareClass12024-03-3107596770ns10:OrdinaryShareClass22024-03-3107596770ns5:RetainedEarningsAccumulatedLosses2023-03-3107596770ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

SSS SURGICAL LIMITED

SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Accountants' Report 9

SSS SURGICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: S S Somers
J H Somers





REGISTERED OFFICE: Russell House
140 High Street
Edgware
Middlesex
HA8 7LW





REGISTERED NUMBER: 07596770 (England and Wales)





ACCOUNTANTS: MGR Paris Limited
Chartered Accountants
Russell House
140 High Street
Edgware
HA8 7LW

SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

BALANCE SHEET
31 MARCH 2024

31.3.24 31.3.23
Notes £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 41,302 50,471
Investments 6 66,667 66,667
107,969 117,138

CURRENT ASSETS
Debtors 7 6,685 67,803
Cash at bank 1,029,466 958,516
1,036,151 1,026,319
CREDITORS
Amounts falling due within one year 8 (35,610 ) (43,671 )
NET CURRENT ASSETS 1,000,541 982,648
TOTAL ASSETS LESS CURRENT LIABILITIES 1,108,510 1,099,786

PROVISIONS FOR LIABILITIES (10,326 ) (12,618 )
NET ASSETS 1,098,184 1,087,168

CAPITAL AND RESERVES
Called up share capital 9 10,100 10,100
Retained earnings 10 1,088,084 1,077,068
SHAREHOLDERS' FUNDS 1,098,184 1,087,168

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 September 2024 and were signed on its behalf by:





S S Somers - Director


SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

SSS Surgical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures and fittings - 10% on cost
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Interest payable
Interest payable is charged to the profit and loss account on an accruals basis.

Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short term liquid investments with original maturities of three months or less.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued

Basic financial assets
Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction and where material are subsequently measured at amortise cost using the effective interest method, less any impairment

Impairment of financial assets
Financial assets, other than those held at fair value are assessed for indicators or impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occured after the initial recognition of the financial asset, the estimated future cash flows have been affected. The impairment loss is recognised in the Statement of Total Comprehensive Income.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfer the financial asset and substantially all the risks and rewards of ownership to another entity.

Basic financial liabilities
Basic financial liabilities, including trade and other payables and loans from company undertakings that are classified as debt are initially measured at transaction price unless the arrangement constitute a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at the market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired int he ordinary course of business from suppliers. Accounts payables are classified as current liabilities if a payment is due within one year or less. If not, they are present as non current liabilities. Short term creditors are initially recognised at transaction price and where material are subsequently measured at amortised cost using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 13,125
AMORTISATION
At 1 April 2023
and 31 March 2024 13,125
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 -

SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2023 11,757 60,390 9,636 81,783
Additions - - 4,717 4,717
At 31 March 2024 11,757 60,390 14,353 86,500
DEPRECIATION
At 1 April 2023 11,640 15,098 4,574 31,312
Charge for year 118 11,323 2,445 13,886
At 31 March 2024 11,758 26,421 7,019 45,198
NET BOOK VALUE
At 31 March 2024 (1 ) 33,969 7,334 41,302
At 31 March 2023 117 45,292 5,062 50,471

6. FIXED ASSET INVESTMENTS
Unlisted
investments
£   
COST
At 1 April 2023
and 31 March 2024 66,667
NET BOOK VALUE
At 31 March 2024 66,667
At 31 March 2023 66,667

SSS Surgical Limited holds 14.67% of equity interest in Streamline Clinics Limited.

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 6,125 53,913
Other debtors 560 13,890
6,685 67,803

SSS SURGICAL LIMITED (REGISTERED NUMBER: 07596770)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Taxation and social security 30,368 39,229
Other creditors 5,242 4,442
35,610 43,671

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
100 Ordinary B 1 100 100
10,000 Ordinary 1 10,000 10,000
10,100 10,100

10. RESERVES
Retained
earnings
£   

At 1 April 2023 1,077,068
Profit for the year 91,016
Dividends (80,000 )
At 31 March 2024 1,088,084

11. RELATED PARTY DISCLOSURES

S S Somers and J H Somers

Directors


31.3.24 31.3.23
£    £   
Amount due to related party at the balance sheet date 1,194 393

ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
SSS SURGICAL LIMITED


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of SSS Surgical Limited for the year ended 31 March 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of SSS Surgical Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of SSS Surgical Limited and state those matters that we have agreed to state to the Board of Directors of SSS Surgical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than SSS Surgical Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that SSS Surgical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of SSS Surgical Limited. You consider that SSS Surgical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of SSS Surgical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






MGR Paris Limited
Chartered Accountants
Russell House
140 High Street
Edgware
HA8 7LW


4 September 2024